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SUMMARY
The BCL-2 family proteins are central regulators of
apoptosis. However, cells deficient for BAX and
BAK or overexpressing BCL-2 still succumb to
oxidative stress upon DNA damage or matrix detach-
ment. Here, we show that DNp63a overexpression
protects cells from oxidative stress induced by oxi-
dants, DNA damage, anoikis, or ferroptosis-inducing
agents. Conversely, DNp63a deficiency increases
oxidative stress. Mechanistically, DNp63a orches-
trates redox homeostasis through transcriptional
control of glutathione biogenesis, utilization, and
regeneration. Analysis of a lung squamous cell carci-
noma dataset from The Cancer Genome Atlas
(TCGA) reveals that TP63 amplification/overexpres-
sion upregulates the glutathione metabolism
pathway in primary human tumors. Strikingly, over-
expression of DNp63a promotes clonogenic survival
of p53/Bax/Bak/ cells against DNA damage.
Furthermore, co-expression of BCL-2 and DNp63a
confers clonogenic survival against matrix detach-
ment, disrupts the luminal clearance of mammary
acini, and promotes cancer metastasis. Our findings
highlight the need for a simultaneous blockade of
apoptosis and oxidative stress to promote long-
term cellular well-being.
INTRODUCTION
Proper execution of cell death ensures normal biological
processes, and its deregulation causes human diseases ranging
from cancer to neurodegenerative disorders (Thompson, 1995).
The evolutionarily conserved signaling cascade, consisting of
the BCL-2 family, the adaptor protein Apaf-1, and the caspase
family, outlines the quintessential apoptotic network (Wang,
2001). In response to apoptotic signals, the ‘‘activator’’ BH3-
only molecules, including BID, BIM, PUMA, and NOXA, trigger
homo-oligomerization of BAX and BAK to permeabilize mito-
chondria, leading to efflux of cytochrome c for caspase activa-
tion (Chen et al., 2015; Cheng et al., 2001; Inoue-Yamauchi
et al., 2017; Kim et al., 2006, 2009; Ren et al., 2010; Wang,
2001; Wei et al., 2001). Although apoptosis has long been
considered as the major cell death mechanism required for the
successful development and maintenance of tissue homeosta-
sis in metazoans, double deficiency of Bax and Bak only disrupts
the development and homeostasis in restricted sets of tissues
(Lindsten et al., 2000), suggesting the existence of BAX/BAK-in-
dependent cell death mechanism(s) in maintaining a tissue
homeostatic state.
In exploring this cell death conundrum, we discovered that
apoptosis-deficient Bax/Bak/ double-knockout (DKO)
mouse embryonic fibroblasts (MEFs) underwent a regulated
form of necrotic cell death in response to DNA damage induced
by topoisomerase inhibitors (Tu et al., 2009). Surprisingly, this
type of necrotic cell death requires active transcription/transla-
tion (Tu et al., 2009). Because this DNA damage-induced
programmed necrotic death (PND) does not require RIP1 and
is not blocked by inhibitors of RIP1 and RIP3, it is distinct from
tumor necrosis factor (TNF)-induced ‘‘necroptosis’’ (Pasparakis
and Vandenabeele, 2015; Sun and Wang, 2014; Yuan and
Kroemer, 2010; Figure S1). Furthermore, we have reported that
this death is independent of caspases, the mitochondrial perme-
ability transition pore (PTP), autophagy, and poly(ADP-ribose)
polymerase (PARP) (Tu et al., 2009). Notably, DNA alkylation
induces PARP-dependent necrotic death, whereas double-
strand DNA breaks induce PARP-independent necrotic death
in DKO cells (Tu et al., 2009; Zong et al., 2004). Mechanistically,
we have delineated a p53-cathepsin axis that cooperates with
ROS (reactive oxygen species) to activate PND in DKO cells
undergoing double-strand DNA breaks (Tu et al., 2009).
Similar to DNA damage-induced cell death, it was reported
that inhibition of apoptosis by BCL-2 is insufficient to provide
long-term clonogenic survival against anoikis (Schafer et al.,
2009), a form of cell death that is induced by detachment from
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the extracellular matrix in anchorage-dependent cells. Interest-
ingly, the antioxidant Trolox cooperates with BCL-2 to enhance
clonogenic survival and prevent the luminal clearance of acini
in 3D culture of mammary epithelial cells (Schafer et al., 2009).
Hence, although apoptosis is the fastest mechanism for elimi-
nating cells upon death stimuli, inhibition of apoptosis is insuffi-
cient to confer long-term clonogenic survival, which is required
to prevent the pathological loss of cells during disease pro-
cesses. ROS appears to play a critical role in abrogating long-
term clonogenic survival. The importance of ROS in regulating
cell death is further exemplified by the recent characterization
of ferroptosis, an iron-dependent, oxidative form of PND that is
triggered by the depletion of intracellular glutathione or inhibition
of GPX4, leading to accumulation of lipid hydroperoxides (Con-
rad et al., 2016). Of note, ferroptosis is not involved in DNA dam-
age-induced death of Bax/Bak/ cells because ferrostatin-1,
an inhibitor of ferroptosis, failed to protect DKO cells from
etoposide (Figure S1). In contrast, iron chelators protected
Bax/Bak/ cells from etoposide-induced death (Figure S1).
In this study, we sought to identify a master regulator of ROS
and determine whether the identified guardian of oxidative stress
can cooperate with the gatekeepers of mitochondrial apoptosis
(i.e., BCL-2 family proteins) to promote clonogenic survival
against intrinsic cell death signals.
Here we demonstrate that long-term clonogenic survival of
apoptosis-defective cells in response to DNA damage or loss
of matrix attachment could be achieved through overexpression
of the putative oncogene DNp63a, the major isoform of p63.
DNp63a increases cellular resistance against oxidative stress
and ferroptosis by regulating the synthesis, utilization, and
regeneration of glutathione, a central component of the cellular
antioxidant defense system. The regulation of the glutathione
metabolic pathway by DNp63a was further demonstrated in
human squamous cell lung cancer, in which TP63 is frequently
amplified. Amplification of TP63 appears to serve as a mecha-
nism by which squamous cell lung cancer evades oxidative
stress and promotes tumorigenesis. In summary, simultaneous
inhibition of mitochondrion-dependent apoptosis and ROS-
induced cell death can confer long-term cellular survival, a strat-
egy likely hijacked by cancer.
RESULTS
DNp63a Confers Clonogenic Survival of p53/Bax/
Bak/ Triple-Knockout Cells against DNA Damage
through Inhibition of Oxidative Stress
Our prior studies of Bax/Bak/ cells showed that genotoxic
stress-induced, ROS-dependent necrotic death requires active
transcription (Tu et al., 2009), suggesting that genotoxic stress-
induced ROS can be regulated by specific transcription factor(s).
To search for such candidates, we examined several transcrip-
tion factors known to regulate cell death or the DNA damage
response, which led to the discovery of DNp63a as a key tran-
scriptional regulator of ROS. Overexpression of DNp63a
prevented etoposide-induced ROS accumulation in transformed
Bax/Bak/MEFs (Figure 1A). Three ROS-sensitive dyes were
employed to interrogate intracellular ROS levels: 2’,7’-dichloro-
fluorescein diacetate (H2DCFDA), a broad-spectrum ROS
indicator; dihydroethidium (DHE), a specific indicator for super-
oxide; and MitoSOX Red, a specific indicator for mitochondrial
matrix superoxide. Overexpression of DNp63a also reduced
etoposide-induced lipid peroxidation (Figure 1B). Consistent
with our previous characterization of p53 and ROS as two inde-
pendent effectors in executing necrotic death (Tu et al., 2009),
overexpression of a dominant-negative mutant of p53 (p53 DN)
did not prevent ROS induced by genotoxic stress (Figure 1A).
Furthermore, overexpression of either DNp63a or p53 DN
provided only a short-term survival advantage against etoposide
(Figure 1C), whereas co-expression of both DNp63a and p53 DN
enhanced clonogenic survival of DKO cells (Figure 1D). Of note,
we have previously shown that transformation of MEFs by the
SV40 genome does not inactivate p53 (Tu et al., 2009).
To evaluate whether DNp63a regulates ROS independently of
p53, p53/Bax/Bak/ triple-knockout (TKO) MEFs were
generated. Although transformed p53/Bax/Bak/ TKO
MEFs were more resistant to DNA damage than Bax/Bak/
DKO MEFs (Figure S2), TKO cells were eventually killed by
DNA damage because of oxidative stress, which could be allevi-
ated by the antioxidants N-acetyl-L-cysteine (NAC) and dipheny-
leneiodonium (DPI) (Figure S2). Importantly, overexpression of
DNp63a protected TKO cells from etoposide-induced ROS accu-
mulation and cell death (Figures 1E and 1F; Figure S2). Further-
more, inhibition of oxidative stress by DNp63a conferred clono-
genic survival of TKO cells against DNA damage (Figure 1G).
Because BCL-XL amplification/overexpression and p53 muta-
tions can co-occur in human cancers, we next examined whether
DNp63a can inhibit etoposide-induced death in BCL-XL-overex-
pressing p53-deficient MEFs, which resemble p53/Bax/
Bak/ TKO MEFs. Indeed, overexpression of both BCL-XL and
DNp63a, but not either alone, completely blocked etoposide-
induced death of p53/ MEFs (Figure 1H). Notably,
overexpression of BCL-XL provided more protection than
DNp63a because BIM-mediated activation of BAX/BAK occurs
in p53-deficient cells.
It has been reported that another p63 isoform, TAp63, is
induced by DNA damage in MEFs (Flores et al., 2002) and
that deficiency of TAp63, but not p53, protects oocytes from
ionizing irradiation (Suh et al., 2006). Of note, MEFs only
express TAp63 but not DNp63, as determined by qRT-PCR
(Figure S3). However, TAp63 protein was below the immunoblot
detection limit. Knockdown of TAp63 in DKO or TKO MEFs had
no effect on etoposide-induced cell death (Figure S3), indicating
that endogenous TAp63 is not involved in DNA damage-
induced necrotic death and that DNp63a does not inhibit oxida-
tive stress through antagonizing endogenous TAp63 in MEFs.
Consistent with the reported pro-death activity of TAp63a
(Suh et al., 2006), we were unable to stably express TAp63a
in DKO cells. However, when expression of TAp63a was
induced in DKO cells using a lentiviral tetracycline-inducible
system, it neither enhanced nor blocked DNA damage-induced
PND in DKO cells (Figure 1I). Moreover, expression of a human
ectrodactyly, ectodermal dysplasia, and cleft lip/palate (EEC)
syndrome-derived R244H DNp63a mutant (Do¨tsch et al.,
2010; van Bokhoven et al., 2001) that loses DNA binding activity
failed to protect DKO cells from DNA damage-induce cell death
(Figure 1J). These results indicate that binding to DNA, but not
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p53 family members, is critical for DNp63a to prevent DNA
damage-induced necrotic death.
DNp63a Orchestrates Redox Homeostasis through
Transcriptional Control of Glutathione Metabolism
Genes
We envisioned that, if DNp63a prevents DNA damage-induced
oxidative stress by increasing antioxidant capacity, then
DNp63a could protect cells against exogenous oxidants.
Indeed, overexpression of DNp63a protected wild-type (WT)
MEFs from thiol oxidant diamide and the lipid oxidant tert-butyl
hydroperoxide (TBH) (Figure 2A). Given that glutathione is the
major antioxidant produced by the cell and plays a central role
in regulating the intracellular redox state (Meister, 1995;
Trachootham et al., 2009), one testable thesis is that DNp63a
mitigates oxidative stress through transcriptional regulation of
glutathione metabolism genes. Glutathione is synthesized in
two sequential steps that are catalyzed by glutamate-cysteine
A
C
E
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D
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B Figure 1. DNp63a Alleviates DNA Damage-
Induced Oxidative Stress and Enhances
Clonogenic Survival of Transformed
p53/Bax/Bak/ TKO MEFs
(A) SV40-transformed Bax/Bak/ MEFs
transduced with the indicated retrovirus
were untreated or treated with etoposide
(10 mg/mL). Oxidation of the ROS-sensitive dyes
H2DCFDA, DHE, or MitoSOX Red was quantified
by flow cytometry. Data show the fold increase
of ROS after etoposide treatment (mean ± SD,
n = 3).
(B) Cells as described in (A) were subjected to
staining using the lipid peroxidation probe C11-
BODIPY665/676. Oxidation of C11-BODIPY was
quantified by flow cytometry. Data show the fold
increase of lipid peroxidation (LPO) after etoposide
treatment (mean ± SD, n = 3).
(C) Cell death was quantified by propidium iodide
staining 3 days after etoposide treatment (mean ±
SD, n = 3). The expression of N-terminal FLAG-
HA-tagged DNp63a and dominant-negative p53
was assessed by an anti-FLAG immunoblot. The
asterisk denotes a cross-reactive band serving as
a loading control.
(D) SV40-transformed Bax/Bak/ MEFs trans-
duced with the indicated retrovirus were treated
with etoposide for 14 hr. Colonies were stained
with crystal violet after 12 days. The data shown
are representative of three independent experi-
ments.
(E) SV40-transformed p53/Bax/Bak/ MEFs
transduced with the indicated retrovirus were left
untreated or treated with etoposide. Oxidation of
the ROS-sensitive dye DHE was quantified by
flow cytometry. Data show the fold increase
of ROS after etoposide treatment (mean ± SD,
n = 3).
(F) Cell death was quantified by propidium iodide
staining at the indicated times after etoposide
treatment (mean ± SD, n = 3).
(G) c-Myc/Ras- or E1A/Ras-transformed
p53/Bax/Bak/ MEFs transduced with the
indicated retrovirus were treated with etoposide
for 9 hr. Colonies were stained with crystal violet
after 10 days.
(H) SV40-transformed p53/ MEFs transduced with the indicated retrovirus were left untreated or treated with etoposide. Cell death was quantified by pro-
pidium iodide staining at the indicated times (mean ± SD, n = 3).
(I) SV40-transformed Bax/Bak/ MEFs transduced with the indicated retrovirus were left untreated or treated with doxycycline for 2 days, followed by
etoposide treatment for 3 days. Cell death was quantified by propidium iodide staining (mean ± SD, n = 3). The expression of TAp63a was assessed by an anti-
p63 immunoblot. The asterisk denotes a cross-reactive band serving as a loading control.
(J) SV40-transformed Bax/Bak/ MEFs transduced with the indicated retrovirus were left untreated or treated with etoposide. Cell death was quantified by
propidium iodide staining 3 days after etoposide treatment (mean ± SD, n = 3). The expression of WT or mutant DNp63a was assessed by an anti-p63
immunoblot. The asterisk denotes a cross-reactive band serving as a loading control.
*p < 0.05 (Student’s t test).
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ligase (GCL) and glutathione synthetase (GSS), respectively
(Meister, 1995; Figure 2B). It exists in both reduced (glutathione
[GSH]) and oxidized (glutathione disulfide [GSSG]) states (Meis-
ter, 1995). GSH participates in the detoxification of hydrogen
peroxide and lipid hydroperoxides through various glutathione
peroxidases (GPXs) (Figure 2B). During this process, GSH
is oxidized to GSSG, which can then be recycled back to
GSH through the action of glutathione reductase (GSR) at the
expense of reduced nicotinamide adenine dinucleotide
phosphate (NADPH) (Figure 2B). NADPH can be generated by
several enzymes, including isocitrate dehydrogenase 2 (IDH2).
Significantly, gene expression profiling revealed that genes
involved in the glutathione redox pathway were upregulated
A B
C D
E F
G H
Figure 2. DNp63a Controls the Homeosta-
sis of Intracellular Redox through Transcrip-
tional Control of Glutathione Metabolism
Genes
(A) SV40-transformed WT MEFs transduced with
the indicated retrovirus were left untreated or
treated with diamide (100 mM) for 4 hr or tert-butyl
hydroperoxide (TBH, 50 mM) for 7 hr. Cell death
was quantified by propidium iodide staining
(mean ± SD, n = 3).
(B) A schematic of the effect of DNp63a on gluta-
thione metabolism. Overexpression of DNp63a in
cells generates a more reduced intracellular redox
state and increases resistance to oxidative dam-
age through coordinated regulation of glutathione
metabolism genes (highlighted in red). Specifically,
DNp63a upregulates enzymes responsible for
glutathione biosynthesis, ROS detoxification by
glutathione, and regeneration of GSH from GSSG.
(C) SV40-transformed Bax/Bak/ MEFs trans-
duced with the indicated retrovirus were left
untreated or treated with etoposide for 6 hr. The
mRNA levels of the indicated genes were analyzed
by qRT-PCR (mean ± SD, n = 3).
(D) SV40-transformed Bax/Bak/ MEFs trans-
duced with the indicated retrovirus were left
untreated or treated with etoposide for 24 hr.
Intracellular reduced (GSH) and oxidized (GSSG)
glutathione concentrations were determined using
an enzyme-cycling assay and normalized against
protein concentration. Normalized [GSH] and
[GSSG] were used to calculate the GSH/GSSG
ratio (mean ± SD, n = 3).
(E–H) SV40-transformed Bax/Bak/ MEFs sta-
bly expressing GFP or DNp63a were transfected
with scrambled siRNA (siScr) or siRNA against
Gclc (E), Gss (F), Gpx2 (G), or Idh2 (H). Cells were
subsequently left untreated or treated with etopo-
side for 3 days. Cell death was quantified by pro-
pidium iodide staining (mean ± SD, n = 3).
*p < 0.05 (Student’s t test).
in DNp63a-overexpressing cells both
before and after DNA damage (Figure S4).
qRT-PCR confirmed that GCLC (the cata-
lytic subunit of GCL), GSS, IDH2, and
GPX2 were upregulated by DNp63a (Fig-
ure 2C). Hence, it appears that DNp63a
orchestrates a transcription program to coordinate the biosyn-
thesis of glutathione, the utilization of GSH as an antioxidant,
and the regeneration of GSH from GSSG (Figure 2B), the
outcome of which would be an increased GSH-to-GSSG ratio,
indicating a more reduced redox state. Indeed, overexpression
of DNp63a significantly increased the GSH/GSSG ratio in cells
both before and after etoposide treatment (Figure 2D). The func-
tional significance of these DNp63a-induced glutathione
metabolism genes in regulating ROS-induced cell death was
interrogated by small interfering RNA (siRNA)-mediated knock-
down (Figure S3). Knockdown of GCLC, GSS, GPX2, or IDH2
compromised the ability of DNp63a to protect Bax/Bak/
DKO cells against DNA damage to varying extents (Figures
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2E–2H). The protective effect of DNp63a was also mitigated by
the GCLC inhibitor buthionine sulfoximine (BSO) (Figure S4). Of
note, knockdown of these genes also enhanced etoposide-
induced cell death in control DKO cells, but to a lesser degree
(Figures 2E–2H), supporting the involvement of oxidative stress
in this form of cell death. Collectively, our data show that
DNp63a orchestrates a tightly coupled glutathione metabolic
circuit to alleviate oxidative stress (Figure 2B), protecting
apoptosis-defective cells from ROS-mediated necrotic cell
death.
Because DNA binding activity is required for DNp63a to
alleviate oxidative stress, we searched for the p63 response
element in glutathionemetabolism genes (Hoh et al., 2002; Perez
et al., 2007). Potential p63 binding sites were identified in intron 1
of GCLC and GPX2. Direct targeting of DNp63a to these sites
was demonstrated by chromatin immunoprecipitation (ChIP)
Figure 3. DNp63a Regulates Glutathione
Metabolism and Oxidative Stress-Induced
Cell Death Independent of NRF2
(A) SV40-transformed Bax/Bak/ MEFs trans-
duced with a control or DNp63a-expressing retro-
virus were subjected to chromatin immunoprecipi-
tation using the anti-p63 antibody, followed by PCR
amplification of intron 1 of Gclc and Gpx2,
respectively. A 50 sequence located 3–4 kb
upstream of the transcription start site of Gclc or
Gpx2 served as a negative control.
(B) SV40-transformed Bax/Bak/ DKO MEFs
transduced with the indicated retrovirus were left
untreated or treated with etoposide. Cell death
was quantified by propidium iodide staining
(mean ± SD, n = 3).
(C) SV40-transformed Bax/Bak/ MEFs trans-
duced with retrovirus expressing GFP or DNp63a
were transfected with siScr or siRNA against Nrf2
(Nfe2l2). The mRNA levels of Nrf2 (Nfe2l2) and Gclc
were analyzed by qRT-PCR (mean ± SD, n = 3).
(D) Protein lysates from cells described in (C) were
analyzed by immunoblots using the indicated
antibodies.
(E) SV40-transformed Bax/Bak/ MEFs stably
expressing GFP or DNp63a were transfected with
scrambled siRNA or siRNA against Nrf2 (Nfe2l2).
Cells were subsequently left untreated or treated
with etoposide for 3 days. Cell death was quantified
by propidium iodide staining (mean ± SD, n = 3).
(F) SV40-transformed Bax/Bak/ MEFs trans-
duced with the indicated retrovirus were analyzed
by immunoblots using the indicated antibodies.
*p < 0.05 (Student’s t test).
assays (Figure 3A), which is consistent
with a previous report showing direct
regulation of GPX2 by p63 (Yan and
Chen, 2006). Notably, overexpression of
GCLC or GPX2 alone was insufficient to
protect DKO cells from DNA damage-
induced PND because neither measure
would sustain the regeneration of GSH
from GSSG (Figures 3B and 2B). These
results highlight the importance of DNp63a in orchestrating a
tightly coupled glutathionemetabolic circuit in maintaining redox
homeostasis. Because NRF2 (NFE2L2) is the most studied tran-
scription factor that controls the expression of antioxidant
genes, including GCLC (Motohashi and Yamamoto, 2004), we
investigated whether DNp63a regulates GCLC through NRF2.
Knockdown of Nrf2 (Nfe2l2) had a minimal effect on DNp63a-
mediated upregulation of GCLC even though it partially reduced
GCLC in control cells (Figures 3C and 3D). Consequently, the
protective effect of DNp63a against DNA damage-induced
necrotic death was not affected by NRF2 loss (Figure 3E).
Furthermore, the DNA-binding incompetent R244H mutant of
DNp63a failed to upregulate GCLC (Figure 3F). In summary,
these data not only illustrate an NRF2-independent regulation
of GCLC by DNp63a but also indicate that DNp63a is a central
regulator of glutathione biogenesis.
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Deficiency of DNp63a Generates a More Oxidized
Intracellular Redox State and Sensitizes Cells to
Oxidative Stress
To investigate the role of endogenous DNp63a in regulating
redox homeostasis, knockdown of p63 using a validated small
hairpin RNA (shRNA) that targets all p63 isoforms (Godar et al.,
2008) was performed in cell lines where DNp63a but not
TAp63 protein was detected by immunoblots (Figure 4A).
Consistent with our gain-of-function studies, knockdown of
endogenous DNp63a led to increased intracellular ROS in the
human mammary epithelial cell line MCF-10A and the cervical
carcinoma cell line ME-180 (Figure 4B). Knockdown of
DNp63a using miR30-based shRNA or siRNA specific for
DNp63 also increased ROS (Figure S5). Because MCF-10A cells
A B
C
D
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Figure 4. Deficiency ofDNp63aGenerates a
More Oxidized Intracellular Redox State and
Sensitizes Cells to Oxidative Stress
(A) MCF-10A or ME-180 cells transduced with
lentivirus expressing shRNA against GFP or TP63
were analyzed by immunoblots using the indicated
antibodies.
(B) MCF-10A or ME-180 cells transduced with
lentivirus expressing shRNA against GFP or TP63
were stained with CM-H2DCFDA or H2DCFDA.
Oxidation of the respective dyes was quantified by
flow cytometry. Data show the fold increase of
ROS induced by knockdown of p63 (mean ± SD,
n = 3).
(C) MCF-10A or ME-180 cells were transduced
with lentivirus expressing shRNA against GFP or
TP63. The mRNA levels of the indicated genes
were analyzed by qRT-PCR (mean ±SD, n = 3).
(D) MCF-10A or ME-180 cells transduced with
lentivirus expressing shRNA against GFP or TP63
were analyzed for intracellular reduced (GSH) and
oxidized (GSSG) glutathione concentrations using
an enzyme-cycling assay. Normalized [GSH] and
[GSSG] were used to calculate the GSH/GSSG
ratio (mean ± SD, n = 3).
(E) MCF-10A or ME-180 cells transduced with
lentivirus expressing shRNA against GFP or TP63
were left untreated or treated with the oxidant
diamide in combination with the antioxidant NAC
for 6 hr (MCF-10A) or 4 hr (ME-180). Cell death
was quantified by propidium iodide staining
(mean ± SD, n = 3).
*p < 0.05 (Student’s t test).
have been reported to express low levels
of TAp63 that are below the immunoblot
detection limit (Figure 4A), knockdown of
either TAp63 or DNp63a was performed
in MCF-10A cells using isoform-specific
siRNA. Knockdown of DNp63a increased
ROS, whereas knockdown of TAp63
increased DNp63 expression and slightly
reduced ROS (Figure S5). Together, these
results support that DNp63a suppresses
ROS accumulation. Importantly, qRT-
PCR showed that DNp63a knockdown
downregulated GCLC, GSS, IDH2, and GPX2 (Figure 4C)—the
same set of genes that was upregulated by DNp63a (Figure 2C).
Of note, GSRwas suppressed by loss of endogenous DNp63a in
human cells but not induced by DNp63a overexpression in
MEFs (Figure 4C and data not shown), which might reflect
cell-type-specific regulation. Consistent with downregulation of
glutathione metabolism genes by DNp63a knockdown, the
GSH/GSSG ratio was reduced in cells deficient for DNp63a (Fig-
ure 4D), indicating a more oxidized redox state. Consequently,
DNp63a knockdown enhanced diamide-induced cell death,
which was blocked by NAC (Figure 4E). Furthermore, DNp63a
knockdown slightly increased baseline cell death over time and
sensitized cells to chemotherapeutic agent-induced cell death
(Figure S5). Altogether, our loss-of-function studies revealed
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an important role of endogenous DNp63a in maintaining redox
homeostasis.
DNp63a Can Inhibit Ferroptosis Independent of p53
Given that DNp63a orchestrates glutathione homeostasis and
glutathione depletion induces ferroptosis, we envisioned that
DNp63a might inhibit ferroptosis. Because p53 is reported to
positively regulate ferroptosis through transcriptional repression
of Slc7a11 (Jiang et al., 2015), a central component of the
cystine-glutamate antiporter (system Xc
), and DNp63a can
potentially function as a dominant-negative regulator of p53,
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Figure 5. DNp63a Can Inhibit Ferroptosis
Independent of p53
(A) SV40-transformed WT MEFs transduced with
GFP or DNp63-expressing retrovirus were left
untreated or treated with erastin (4 mM) for the
indicated times. Cell death was quantified by
propidium iodide staining (mean ± SD, n = 3).
(B) SV40-transformed p53/ MEFs transduced
with GFP or DNp63-expressing retrovirus were left
untreated or treated with erastin (4 mM) for the
indicated times. Cell death was quantified by
propidium iodide staining (mean ± SD, n = 3).
(C) SV40-transformed WT or p53/ MEFs trans-
duced with GFP or DNp63-expressing retrovirus
were left untreated or treated with RSL3 (1 mM) for
8 hr. Cell death was quantified by propidium iodide
staining (mean ± SD, n = 3).
(D) SV40-transformed WT or p53/ MEFs trans-
duced with retrovirus expressing GFP or DNp63
were subjected to qRT-PCR analysis of Slc7a11
mRNA. Data were normalized against b-actin
(mean ± SD, n = 3).
(E) ME-180 cells, transfected with scrambled
siRNA or siRNA againstDNp63, were left untreated
or treated with erastin (20 mM) for 72 hr. Cell death
was quantified by propidium iodide staining
(mean ± SD, n = 3).
(F) ME-180 cells, transfected with scrambled
siRNA or siRNA againstDNp63, were left untreated
or treated with RSL3 (10 mM) for 48 hr. Cell death
was quantified by propidium iodide staining
(mean ± SD, n = 3).
(G) ME-180 cells, transfected with scrambled
siRNA or siRNA against DNp63, were subjected
to qRT-PCR analysis of the indicated genes
(mean ± SD, n = 3).
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test).
we compared the effect ofDNp63a on fer-
roptosis in both WT and p53/ MEFs.
Consistent with the published results
(Jiang et al., 2015), p53 deficiency pro-
tected MEFs from ferroptosis induced
by erastin but only at an early time point
(Figures 5A and 5B). Overexpression of
DNp63a protected both WT and p53/
MEFs from erastin-induced death, sug-
gesting that the anti-ferroptotic activity
of DNp63a is independent of p53. Similar
results were observed in RSL3-induced
ferroptosis (Figure 5C). Although the effect of DNp63a on gluta-
thione homeostasis is probably sufficient to inhibit ferroptosis,
DNp63a may also regulate the expression of Slc7a11 directly
or indirectly through p53. Interestingly, DNp63a upregulated
Slc7a11 expression in p53/ but not in WT MEFs, where p53
suppressed Slc7a11 expression (Figure 5D), suggesting that
DNp63a is unable to abrogate p53-mediated transcriptional
repression of Slc7a11. Together, these findings suggest that
the protective effect of DNp63a against ferroptosis is probably
due to its transcriptional control of glutathionemetabolism genes
in WT MEFs, whereas its regulation of Slc7a11 further
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Figure 6. DNp63aMitigates Anoikis-Induced Oxidative Stress and Cooperates with Anti-Apoptotic BCL-2 to Disrupt the Luminal Clearance
of Mammary Acini and Promote Cancer Metastasis
(A) MCF-10A or ME-180 cells were grown on poly-HEMA-coated plates in the presence of 1%methylcellulose for 12 hr to induce anoikis. Paired samples grown
under either regular or detachment conditions were assessed by anti-p63 and anti-actin immunoblots.
(B) MCF-10A cells transduced with the indicated retrovirus were grown on poly-HEMA-coated plates in the presence of 1% methylcellulose to induce anoikis.
Paired samples grown under either regular or detachment conditions were stained with DHE at 1.5 days. Oxidation of DHEwas quantified by flow cytometry. Data
show the fold increase of ROS induced by anoikis (mean ± SD, n = 3).
(legend continued on next page)
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contributes to its anti-ferroptotic activity in p53-deficient
MEFs. We subsequently performed loss-of-function studies of
DNp63a in ME-180 cells that are HPV-positive. DNp63a knock-
down enhanced ferroptosis and downregulated SLC7A11
expression in ME-180 cells (Figures 5E–5G), which is consistent
with our gain-of-function studies in MEFs. In contrast, TAp63
knockdown in ME-180 cells neither reduced SLC7A11 expres-
sion nor enhanced ferroptosis (Figure S5). Overall, our data sug-
gest that DNp63a can inhibit ferroptosis independent of p53.
DNp63a Alleviates Anoikis-Induced Oxidative Stress
and Cooperates with BCL-2 to Disrupt the Luminal
Clearance of Mammary Acini and Promote Metastasis
The observation that antioxidants and anti-apoptotic BCL-2
work in concert to promote long-term clonogenic survival
against matrix detachment (Schafer et al., 2009) prompted us
to investigate whether DNp63a can mitigate oxidative stress
associated with anoikis and whether DNp63a can cooperate
with BCL-2 to prevent the luminal clearance of acini in 3D culture
of MCF-10A cells. Interestingly, loss of matrix attachment led to
downregulation of DNp63a in both MCF-10A and ME-180 cells,
where DNp63a knockdown induced oxidative stress (Figures 6A
and 4B). Notably, overexpression of DNp63a, but not BCL-2,
prevented matrix detachment-induced ROS accumulation in
MCF-10A cells even though DNp63a provided less protection
against cell death than BCL-2 (Figures 6B and 6C). To investigate
long-term survival upon loss of matrix attachment, MCF-10A
cells were seeded onto a reconstituted basement membrane
under conditions that enable the formation of 3D acini, where
the inner, matrix-deprived cells are eliminated to facilitate lumen
formation (Schafer et al., 2009). Overexpression of either BCL-2
or DNp63a only weakly inhibited luminal clearance, whereas
co-expression of BCL-2 and DNp63a markedly blocked luminal
clearance (Figures 6D and 6E). Luminal clearance of MCF-10A
acini was evident within 2 weeks after seeding, whereas
co-expression of BCL-2 and DNp63a potently blocked luminal
clearance for up to 1 month (Figures 6D and 6E). Importantly,
overexpression of DNp63a, but not BCL-2, suppressed ROS
accumulation in the matrix-deprived luminal cells at early time
points before these cells were eliminated (Figure 6F). Both
TAp63 and DNp63 have been shown to regulate the expression
of adhesion molecules, and adenovirus-mediated knockdown of
p63 was reported to induce anoikis (Carroll et al., 2006). How-
ever, we did not observe obvious adhesion problems when
p63 was silenced, which is in accordance with a previous report
(Senoo et al., 2007). Notably, only DNp63, but not TAp63, is
capable of regulating oxidative stress (Figure 1I; Figure S5).
Ferrostatin-1 had minimal effect on the luminal clearance of
mammary acini in 3D culture (Figure S6).
Because resistance to anoikis has been proposed to promote
cancer metastasis, and oxidative stress has been shown to limit
cancer metastasis (Buchheit et al., 2014; Piskounova et al.,
2015), we next examined whether overexpression of DNp63a
and/or BCL-2 promotes lung metastasis of a triple-negative
breast cancer cell line, MDA-MB-231, that is transduced with
luciferase for bioluminescence imaging. Tail vein injection of
DNp63a-overexpressing, luciferase-transduced MDA-MB-231
cells into immunodeficient mice resulted in lung metastases in
2 of 5 mice, whereas GFP-expressing control cells failed to
metastasize to the lungs (Figures 6G and 6H). These findings
are consistent with a report showing that NAC increases the
metastatic melanoma burden because of increased ROS and
reduced GSH/GSSG ratios in metastatic tumors (Piskounova
et al., 2015). Although overexpression of BCL-2 alone did not
increase lung metastasis, co-expression of BCL-2 and DNp63a
further increased lung metastases, and 4 of 5 mice, following
injection, developed lung metastases (Figures 6G and 6H). In
summary, combined inhibition of apoptosis and oxidative stress
through co-expression of BCL-2 and DNp63a confers clono-
genic survival against anoikis and promotes lung metastasis.
Amplification of TP63 in Human Squamous Cell Lung
Cancer Upregulates Glutathione Metabolism Genes to
Promote Anchorage-Independent Growth
In contrast to the tumor suppressor function of p53, DNp63a has
been implicated as an oncogene and is frequently amplified an-
d/or overexpressed in human squamous cell carcinoma of the
lung and of the head and neck (Do¨tsch et al., 2010; Keyes
et al., 2011; Tonon et al., 2005). Because cancers often have
an increased demand for antioxidant capacity compared with
normal tissues, likely because of inherent metabolic derange-
ments that increase ROS production (Trachootham et al.,
2009),DNp63amight promote tumorigenesis by reducing oxida-
tive stress. To explore this possibility, we analyzed a lung squa-
mous cell carcinoma dataset from The Cancer Genome Atlas
(TCGA) (Cancer Genome Atlas Research Network, 2012) to
determine whether amplification/overexpression of p63 upregu-
lates the glutathione metabolism pathway in primary human
tumors. Consistent with previously published reports (Do¨tsch
et al., 2010; Tonon et al., 2005), TP63 amplification is a frequent
(C)MCF-10A cells transducedwith the indicated retroviruswere grown on poly-HEMA-coated plates in the presence of 1%methylcellulose to induce anoikis. Cell
death was quantified by annexin-V staining at the indicated times (mean ± SD, n = 3).
(D and E)MCF-10A cells transducedwith the indicated retrovirus were cultured in a reconstituted basementmembrane (Matrigel) for 31 days. Acini were fixed and
stained for Laminin 5 (red) and the nuclear stain DAPI (blue). The luminal cellularity of acini was scored using confocal microscopy: clear, 0%–25% of the luminal
space filled with cell nuclei; mostly clear, 25%–50%; mostly filled, 50%–75%; filled, 75%–100%. Representative confocal microscopy images from three
independent experiments are shown in (D). Scale bars, 25 mm. The data shown in (E) are the average of three independent experiments.
(F) MCF-10A cells transduced with the indicated retrovirus were cultured in Matrigel for 6–8 days. Acini were stained with DHE (red) and Hoechst 33342 (blue).
Representative confocal microscopy images are shown. Arrowheads indicate DHE-high cells. Scale bars, 25 mm.
(G) Luciferase-transduced MDA-MB-231 cells overexpressing GFP, BCL-2, DNp63a, or both DNp63a and BCL-2 were injected into the tail vein of immuno-
deficient mice, and lung colonization was analyzed by in vivo bioluminescence imaging (n = 5 for each group).
(H) Representative histopathological images of lungs with metastatic tumors (black dashed circle) from mice injected with luciferase-transduced MDA-MB-231
cells overexpressing DNp63a or both DNp63a and BCL-2. Scale bars, 100 mm.
*p < 0.05 (Student’s t test).
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Figure 7. Amplification of TP63 in Human Squamous Cell Lung Cancer Upregulates Glutathione Metabolism Genes and Promotes
Anchorage-Independent Growth
(A) Heatmap of expression levels of Kyoto Encyclopedia of Genes and Genomes (KEGG) glutathione metabolism pathway genes in the TCGA lung squamous cell
carcinoma samples harboring amplified or diploid TP63 as indicated. The expression levels are plotted in a red-blue color scale, with red indicating high
expression and blue indicating low expression.
(B) GSEA enrichment plot demonstrating enrichment of the KEGG glutathione metabolism pathway in TCGA lung squamous cell carcinoma samples with
amplified TP63 compared with diploid samples. Nominal p = 0.00766. False discovery rate (FDR) q = 0.019.
(C–E) Pairwise comparison of mRNA expression of TP63 versus GCLC (C), GPX2 (D), or GSR (E) in TCGA lung squamous cell carcinoma samples harboring
amplified TP63 with Pearson correlation and p values shown.
(legend continued on next page)
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event in human lung squamous cell carcinoma (30%), and the
majority of TP63-amplified tumors overexpress DNp63. We
further interrogated the database using gene set enrichment
analysis (GSEA) and found that tumor samples harboring TP63
amplification and overexpressing DNp63 had significant enrich-
ment of glutathione metabolic pathway genes compared with
diploid tumor samples (Figures 7A and 7B). Furthermore, within
the TP63-amplified subset, DNp63 expression levels positively
correlated with the expression of several genes that were
discovered through our mechanistic studies, including GCLC
(pairwise correlation coefficient [r] = 0.49, p = 8.49e07), GPX2
(r = 0.52, p = 1.48e07), and GSR (r = 0.46, p = 7.29e06)
(Figures 7C–7E).
Given that oxidative stress is induced in response to matrix
detachment, the ability of cells to form colonies in soft agar is
not only determined by their proliferative potential but also by
their resistance to oxidative stress. We next examined whether
DNp63a promotes anchorage-independent growth by inhibiting
oxidative stress. Indeed, overexpression of DNp63a in a squa-
mous cell lung cancer cell line, H520, with low DNp63a expres-
sion increased soft agar colony formation without enhancing
cell proliferation (Figure 7F and data not shown). In contrast,
DNp63a knockdown in a squamous cell lung cancer cell line,
HCC95, that highly expresses DNp63a led to increased ROS
accumulation and reduced soft agar colony formation (Figures
7G and 7H). Because genomic amplification on chromosome
3q26.33 harbors an oncogene, SOX2, in addition to TP63
(Bass et al., 2009), we envisioned that SOX2 and DNp63a might
cooperate to promote oncogenesis. Consistent with a previous
report (Bass et al., 2009), overexpression of SOX2 alone only
slightly increased colony formation in soft agar (Figure 7I). Signif-
icantly, SOX2 and DNp63a synergized to transform normal
human bronchial epithelial cells, BEAS-2B (Figure 7I). Collec-
tively, these data support the notion that amplification of TP63
may be a strategy by which squamous cell lung cancer evades
oxidative stress and, thereby, promotes tumorigenesis.
DISCUSSION
Here we report thatDNp63a prevents oxidative stress and coop-
erates with apoptotic inhibition to promote long-term cellular
survival against DNA damage and extracellular matrix detach-
ment, highlighting the quintessence of suppressing oxidative
stress in promoting long-term survival (Figure S7). Caspase-
dependent apoptosis has long been considered the predomi-
nant pathway for cell death. Apoptosis can be initiated through
either intrinsic death signals, such as DNA damage, loss of
matrix attachment, cytokine/growth factor deprivation, and
endoplasmic reticulum (ER) stress, or extrinsic death signals
that are mediated by the ligand engagement of death receptors,
including FAS and TNF-R1. Studies of extrinsic cell death
discovered a necrotic program, necroptosis, when apoptosis is
inhibited (Pasparakis and Vandenabeele, 2015; Sun and Wang,
2014; Yuan and Kroemer, 2010). The discovery of programmed
forms of necrotic death represents a significant conceptual
advance for cell death research. However, it remains unsettled
whether intrinsic death signals also activate necrosis and
whether intrinsic necrosis, if it exists, is also programmed. We
and others have previously shown that cells incompetent of un-
dergoing apoptosis still succumb to oxidative stress upon DNA
damage or loss of matrix attachment and display morphological
features of necrosis (Schafer et al., 2009; Tu et al., 2009). The
current study showed that oxidative stress-induced necrotic
death in these settings could be blocked by overexpression of
DNp63a through coordinated regulation of glutathione biosyn-
thesis, utilization, and regeneration. In fact, DNp63a guards
against oxidative stress triggered by a wide array of death stimuli
in several different cell lines, including intrinsic apoptotic signals,
thiol or lipid oxidants, and ferroptosis-inducing agents. These
data support the hypothesis that DNp63a is a key cellular guard-
ian against oxidative stress analogous to antiapoptotic
BCL-2 family proteins that act at the convergence of diverse
apoptosis-inducing signaling pathways. Overall, our data
support the theory that intrinsic death signals can trigger necro-
sis when apoptosis is inhibited and intrinsic necrosis is also
programmed.
Inhibition of oxidative stress may be especially critical to the
well-being of long-lived cells such as stem cells (Holmstro¨m
and Finkel, 2014; Kobayashi and Suda, 2012). Because stem
cells must remain capable of both self-renewal and repletion of
lost progeny throughout an organism’s lifespan, they are
expected to be more tolerant to the long-term exposure to
ROS and oxidative stress. In fact, DNp63a is important in main-
taining the stem cell populations of stratified epithelia (Do¨tsch
et al., 2010; Keyes et al., 2011; Senoo et al., 2007). In addition
to sustaining the proliferative capacity of epithelial stem cells
as proposed previously (Keyes et al., 2011; Senoo et al., 2007),
our data imply that DNp63amay also promote stem cell survival
through its antioxidant function. Intriguingly, p63+/ mice have a
shortened lifespan and display features of accelerated aging,
and p63-deficient cells exhibit heightened cellular senescence
(Keyes et al., 2005), all of which could be caused by oxidative
damage (Balaban et al., 2005) and may be linked to oxidative
stress resulting from the loss of DNp63a.
Our findings highlight the need for a simultaneous blockade of
apoptosis and oxidative stress to promote long-term cellular
(F) H520 cells transduced with control retrovirus or retrovirus expressingDNp63awere plated in soft agar for 18 days. Colonies with diameters larger than 200 mm
were counted (mean ± SD, n = 3). Representative images are shown (scale bars, 200 mm).
(G) HCC95 cells transduced with lentivirus expressing shRNA against GFP or TP63 were stained with CM-H2DCFDA or subjected to immunoblot analysis using
the indicated antibodies. Oxidation of CM-H2DCFDA was quantified by flow cytometry. Data show the fold increase of ROS induced by knockdown of TP63
(mean ± SD, n = 3).
(H) HCC95 cells transduced with lentivirus expressing control or shRNA against TP63 were plated in soft agar for 12 days. Colonies with diameters larger than
200 mm were counted (mean ± SD, n = 3). Representative images are shown (scale bars, 200 mm).
(I) BEAS-2B cells transduced with the indicated retrovirus were plated in soft agar for 18 days. Colonies with diameters larger than 200 mm were counted
(mean ± SD, n = 3). Representative images are shown (scale bars, 200 mm).
*p < 0.05 (Student’s t test).
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well-being, a strategy likely hijacked by cancer. To evade
apoptotic checkpoints, cancer cells often overexpress anti-
apoptotic BCL-2 family proteins through chromosome translo-
cation involving BCL-2 (Korsmeyer, 1992) or amplification of
BCL-XL andMCL-1 (Beroukhim et al., 2010). Likewise, amplifica-
tion of TP63 can be a strategy for cancer cells to evade oxidative
stress-induced cell death. The importance of antioxidant de-
fense in tumorigenesis is also supported by the discovery of
frequent loss-of-function mutations of KEAP1 and gain-of-func-
tion mutations ofNRF2 in human cancers (Hayes andMcMahon,
2009). NRF2 controls cellular adaptation to oxidative stress by
inducing antioxidant and detoxification genes, whereas KEAP1
sequesters NRF2 in the cytoplasm and promotes the degrada-
tion of NRF2. Here we showed that DNp63a could regulate
GCLC, the rate-limiting GSH biosynthetic enzyme, through an
NRF2-independent manner, supporting a central role of
DNp63a in glutathione biogenesis. In addition, we showed that
DNp63a could inhibit ferroptosis independent of p53. Given
the recent discovery of ferroptosis regulation as one of the tumor
suppressor mechanisms of p53 (Jiang et al., 2015), suppression
of ferroptosis by DNp63a may contribute to its oncogenic prop-
erties. Our study highlights the importance of evading two cell
deathmechanisms in tumorigenesis, whichmay provide a selec-
tion pressure for genetic/epigenetic alterations with oncogenic
advantages.
Although a detailed blueprint of the core apoptotic pathway
has been constructed through biochemical and genetic studies
over the past two decades, we are still unable to fully rescue cells
from most death stimuli. The identification of oxidative stress as
a critical mechanism compromising long-term survival of
apoptosis-defective cells may open new avenues for therapeutic
interventions aimed at preventing excessive cell loss during
disease processes. Conversely, targeting the antioxidant
pathway may hold promise for the future development of anti-
cancer therapeutics by eliminating cancer cells that evade
apoptotic checkpoints.
EXPERIMENTAL PROCEDURES
Plasmid Construction, Retrovirus Production, and siRNA
Murine DNp63a was dually tagged with FLAG and hemagglutinin (HA) at the
N terminus and cloned into murine stem cell virus (MSCV)-internal ribosome
entry site (IRES)-Puro or tagged with HA at the N terminus and cloned
into MSCV-IRES-GFP. The target sequence of shRNA against mouse p63 is
50-AGCACACGATCGAAACGTA-30. The target sequence of scramble shRNA
is 50- GCGCGCTTTGTAGGATTCG-30. Lentivirus-mediated knockdown con-
structs for human p63 and GFP were described previously (Godar et al.,
2008; Sancak et al., 2008). Lentiviral tetracycline-inducible miR30-based
shRNA against human p63 was obtained from Open Biosystems. The target
sequence is 50-TCCGAGCTATGTCAGTACTATT-30. The siRNA oligos were
purchased from Thermo Fisher Scientific (Silencer Select oligos) or Dharma-
con and summarized in Table S1.
Cell Culture and Viability Assays
Generation and transformation of MEFs were performed as described previ-
ously (Chen et al., 2015; Cheng et al., 2001). The HCC95 cell line was provided
by Dr. John Minna at University of Texas Southwestern Medical Center. To
induce anoikis, cells were grown on plates coated with poly(2-hydroxyethyl
methacrylate) (HEMA; Sigma) in the presence of 1% methylcellulose (Sigma).
Cell death was quantified by annexin-V (BioVision Technologies) or propidium
iodide (Sigma) staining, followed by flow cytometric analysis using either a
FACSCalibur (BD Biosciences) or an LSRFortessa (BD Biosciences). Data
were analyzed using CellQuest Pro (BD Biosciences) or FACSDiva (BD
Biosciences).
Measurement of ROS
Production of ROS was monitored by flow cytometry using redox-sensitive
dyes (Invitrogen), including H2DCFDA, 5-(and-6)-chloromethyl-H2DCFDA
(CM-H2DCFDA), DHE, C11-BODIPY
665/676, or MitoSOX Red. Oxidation of
the ROS-sensitive dyes was quantified by flow cytometry. Median fluores-
cence in the appropriate detection channels was assessed by FlowJo (Tree
Star). Fold induction of ROSwas obtained by dividing themedian fluorescence
of experimental samples by that of control samples.
Reverse Transcription and qPCR
Total RNA was extracted from cells using TRIZOL (Invitrogen), and reverse
transcription was performed with oligo-dT plus random decamer primers
(Ambion) using Superscript II (Invitrogen). Quantitative PCR was performed
with SYBR Green Master Mix (Applied Biosystems) using gene-specific
primers, summarized in Table S2. For TaqMan probes, quantitative PCR
was performed with TaqMan PCRMaster Mix (Applied Biosystems). Quantita-
tive PCR was performed on an ABI Prism 7300 sequence detection system
(Applied Biosystems) or a ViiA 7 real-time PCR system (Applied Biosystems).
Data were analyzed by normalization against GAPDH, b-actin, or 18S rRNA
as described previously (Tu et al., 2009). The TaqMan probes for mouse
GPX2 (TaqMan assay ID Mm00850074_g1) and human GCLC (TaqMan assay
ID Hs00155249_m1) were obtained from Invitrogen.
3D Culture of MCF-10A Cells and Indirect Immunofluorescence
Microscopy
3D culture of MCF-10A cells was performed as described previously (Debnath
et al., 2003). Briefly, 104 cells were seeded onto one chamber of a 4-well cham-
ber slide pre-coated with Matrigel (BD Biosciences). After 31 days, cells were
fixed using 4% paraformaldehyde (Fisher Scientific), permeabilized using
0.5% Triton X-100, and sequentially incubated with anti-Laminin-5 (D4B5,
EMD Millipore), Alexa Fluor 568-conjugated goat anti-mouse immunoglobulin
G (IgG) (Invitrogen), anti-GFP (ab13970, Abcam), Alexa Fluor 488-conjugated
goat anti-chicken IgG (Invitrogen), and the nuclear stain DAPI (Sigma). Images
were acquired using the Leica TCS SP5-II confocal upright and the
PerkinElmer UltraVIEW ERS confocal microscopes at the Molecular Cytology
Core Facility at Memorial Sloan Kettering Cancer Center (MSKCC) and
analyzed by MetaMorph software (Molecular Devices). To measure ROS
levels, 3D culture of MCF-10A cells after 6–8 days was incubated with Hank’s
balanced salt solution (HBSS, Invitrogen) containing 5 mMDHE (Invitrogen) and
3 mg/mL Hoechst 33342 (Invitrogen) at 37C for 30 min in a humidified 5%CO2
incubator, washed once with HBSS, and then imaged immediately.
Reagents, Antibodies, and Immunoblot Analysis
The following chemicals were used: etoposide (Sigma), diamide (Sigma), TBH
(Sigma), DPI (Sigma), NAC (Sigma), ferrostatin-1 (Sigma), necrostatin-1
(Sigma), GSK’872 (EMD Millipore), deferoxamine (Sigma), and Tiron (Sigma).
The following antibodies were used: anti-FLAG (M2, Sigma), anti-p53
(FL393, Santa Cruz Biotechnology), anti-p63 (4A4, Santa Cruz Biotechnology),
anti-GCLC (HPA036359, Sigma), anti-IDH2 (ab55271, Abcam), anti-RIP1
(610458, BD Biosciences), and anti-b-actin (A1978, Sigma). Cell lysates
were resolved by NuPAGE gels (Invitrogen) and transferred onto a polyvinyli-
dene fluoride (PVDF) membrane (Immobilon-P, Millipore). Antibody detection
was accomplished using the enhanced chemiluminescence method (Western
Lightning, PerkinElmer) and the LAS-3000 imaging system (Fujifilm).
Glutathione Assays
Measurement of intracellular GSH and GSSG was performed using the
5,50-dithio-bis(2-nitrobenzoic acid)-glutathione reductase recycling method
as described previously (Rahman et al., 2006). Briefly, the rate of 5-thio-2-ni-
trobenzoic acid (TNB) formation was determined by measuring the rate of
change of absorbance at 412 nm. Linear regressions based on values ob-
tained from standard curves were used to calculate concentrations of total
and oxidized glutathione, which were then used to calculate the concentration
Cell Reports 21, 2926–2939, December 5, 2017 2937
of reduced glutathione. Glutathione concentrations were normalized based on
protein concentration determined using the BCA Kit (Pierce).
Gene Expression Profiling and Heatmap Plot
Total RNAwas extracted from cells using TRIZOL (Invitrogen) and subjected to
cleanup using the RNeasy Mini Kit (QIAGEN). RNA samples were submitted to
the Laboratory for Clinical Genomics at the Washington University in St. Louis
for microarray analysis using the GeneChip Mouse Gene 1.0 ST array (Affyme-
trix). The heatmap plot was generated using the Partek Genomics Suite
(Partek).
Gene Set Enrichment and mRNA Expression Correlation Analysis
GSEA (Subramanian et al., 2005) was used to statistically evaluate the extent
to which genes in the glutathione metabolism pathway (Kyoto Encyclopedia
of Genes and Genomes, KEGG_GLUTATHIONE_METABOLISM, MSigDB
v3.0) were dysregulated in TCGA lung squamous cell carcinoma tumor sam-
ples with TP63 amplification. We first identified tumor samples with diploid
(n = 25) and amplified TP63 (inferred gain of R 2 copies, n = 91). All genes
expressed in tumor samples (n = 107) were sorted by mRNA expression
change in TP63-amplified versus diploid samples (sorting from down- to up-
regulation, Wilcoxon rank-sum test), and GSEA was used to evaluate the null
hypothesis that genes in the glutathione metabolism gene set were not differ-
entially expressed in amplified versus diploid samples (using 1,000 permuta-
tions). Pairwise correlations between TP63 mRNA expression and mRNA
expression levels of genes in the glutathione metabolism pathway in samples
with TP63 amplification were evaluated using the Pearson correlation coeffi-
cient, and regression lines were estimated using the ordinary least-squares
method.
Xenograft Studies
Animal experiments were performed in accordance with the MSKCC Institu-
tional Animal Care and Use Committee. Tail vein injection was performed as
described previously (Minn et al., 2005). Briefly, 2 3 105 cells were injected
into the lateral tail vein of athymic nude mice. Successful injections were
confirmed by bioluminescence imaging. For the imaging, 75 mg/kg of D-Lucif-
erin (Xenogen) in PBS was injected retro-orbitally into anesthetized mice.
Bioluminescence images were obtained with the IVIS imaging system
(Xenogen) and analyzed using Living Image software (Xenogen).
Statistical Analysis
Cell death, ROS induction, qRT-PCR, and glutathione assays were analyzed
for statistical significance using unpaired Student’s t test with alpha = 0.05.
Statistical analysis for GSEA is described above.
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